SARS-CoV-2 and influenza viruses are significant public health threats with varying impacts on global health. SARSCoV- 2, the virus behind the COVID-19 pandemic, exhibits high transmissibility where variants such as Beta, Delta, and Omicron emerged and caused epidemiological waves.
Respiratory illness activity remains at baseline or low levels in the EU/EEA. SARS-CoV-2 is the most prevalent, with case numbers continuing to increase in several countries. Influenza activity remains low overall but is increasing from low levels in several countries. RSV activity remains very low.
The season normally runs from October to April. If you are elderly, pregnant, have a weakened immune system or work in healthcare, now is the time to get vaccinated.
In the EU/EEA, respiratory illness activity remains at baseline or low levels. SARS-CoV-2 is the main contributor, and its circulation continues to increase in several countries. Influenza activity remains low but increases in several countries. RSV activity remains very low.
In the EU/EEA, respiratory illness activity remains at baseline or low levels. SARS-CoV-2 circulation continues to increase in several countries. Influenza and RSV activities remain low.
In the EU/EEA, respiratory illness activity remains at baseline or low levels, although seasonal increases are being observed. While SARS-CoV-2 circulation remains low in most countries, the overall EU/EEA picture is influenced by higher positivity in two countries. Influenza activity is low, while RSV activity remains very low.